Medicine for treating rheumatoid arthritis bone diseases

Abstract

The invention discloses a medicine for treating rheumatoid arthritis bone diseases. The medicine is characterized in that the medicine is prepared by the following raw medicinal materials in parts by weight: 10 to 13 parts of cassia twig, 1 to 2 parts of aconite, 7 to 9 parts of garden balsam stem, 1 to 3 parts of notopterygium root, 1 to 2 parts of asarum, 4 to 6 parts of astragalus membranaceus, 2 to 4 parts of morinda officinalis, 5 to 8 parts of ephedra, 9 to 12 parts of dried ginger, 6 to 9 parts of licorice root, 6 to 9 parts of root of kudzu vine, 4 to 6 parts of fistular onion stalk, 1 to 3 parts of gypsum, 9 to 13 parts of cordyceps sinensis, 8 to 11 parts of snow lotus, and 7 to 10 parts of rhodiola rosea. The medicine for treating the rheumatoid arthritis bone diseases has the advantages that by adopting the pure traditional Chinese medicine ingredients, any toxic and side effect is avoided, the reoccurrence after curing is avoided, and the common rheumatic diseases, such as rheumatism, rheumatoid arthritis, hyperostosis, postpartum rheumatic, lumbar disc herniation, and neck shoulder pain or lumbocrural pain, can be thoroughly treated; the preparation method is simple, the processing and manufacturing are easy, the cost is low, the administration method is simple, and the administration each day is not needed.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicine for treating rheumatic joint bone disease. Background technique [0002] Rheumatic bone disease is mainly a disease caused by poor blood circulation caused by wind and cold, resulting in poor nutritional supply including muscles, ligaments, synovial bursa, and fascia. In addition to pain, joint disease is also accompanied by swelling and movement disorders, showing a chronic course of alternating attacks and remissions, and some patients may experience joint disability and visceral failure. [0003] Rheumatic bone disease is a common disease in my country, and there are nearly 160 million rheumatic patients in China. The disability rate of rheumatism is very high, which seriously affects the work and life of patients. Its main symptoms are pain, soreness, heaviness, numbness, difficulty in flexion and extension, or joint swelling in muscles, joints, muscles and bones, which se...

AI Technical Summary

Problems solved by technology

In the prior art, most of the drugs used to treat rheumatic bone disease contain hormones and analgesic ingredients, ...